06/10/2008
Interleukin Genetics to Present at 2008 BIO International Convention
06/03/2008
Interleukin Genetics to Present at the 13th International Conference on Periodontal Research
05/21/2008
Interleukin Genetics Welcomes the Signing of the Genetic Information Nondiscrimination Act (GINA)
05/14/2008
INTERLEUKIN GENETICS REPORTS FIRST QUARTER 2008 FINANCIAL RESULTS
05/13/2008
Interleukin Genetics to Present at Rodman & Renshaw
05/07/2008
Interleukin Genetics Announces Conference Call and Webcast to Discuss First Quarter 2008 Results
05/01/2008
The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics’ Heart Health Test
04/30/2008
Interleukin Genetics Appoints Eliot M. Lurier Chief Financial Officer
03/27/2008
INTERLEUKIN GENETICS REPORTS FOURTH QUARTER AND YEAR END 2007 FINANCIAL RESULTS
03/18/2008
Interleukin Genetics Retains Top Life Science Communications Firms
02/28/2008
Interleukin Genetics Enters into New Clinical Research Collaboration with Alticor
01/28/2008
INTERLEUKIN GENETICS INC. MANAGEMENT TO PRESENT AT HEALTHCARE CONFERENCES
01/23/2008
INTERLEUKIN GENETICS APPOINTS LEWIS H. BENDER AS CHIEF EXECUTIVE OFFICER
12/19/2007
Interleukin Genetics Annouces Conversion Of $2.04 Million of Debt into Common Stock
11/07/2007
Interleukin Genetics, Inc. Reports Third Quarter 2007 Financial Results
11/01/2007
Interleukin Genetics Enhances Focus on Key Growth Areas Related to Obesity and Gastric Cancer
09/25/2007
Genetic Differences Predict Anti-Inflammatory Benefits From Nutritional Products
09/06/2007
INTERLEUKIN GENETICS ANNOUNCES MANAGEMENT AND BOARD APPOINTMENTS
08/16/2007
INTERLEUKIN INITIATES STUDY OF GENETICS OF OSTEOARTHRITIS WITH NYU
08/09/2007
Interleukin Genetics Reports Second Quarter 2007 Financial Results
07/24/2007
INTERLEUKIN INITIATES PROGRAM TO DEVELOP GENETIC TEST TO GUIDE MORE EFFECTIVE WEIGHT CONTROL
07/16/2007
INTERLEUKIN GENETICS COMPLETES ENROLLMENT OF STUDIES IN JAPAN AND CHINA ON GENETIC RISK
07/03/2007
INTERLEUKIN GENETICS ANNOUNCES EXECUTIVE MANAGEMENT
05/09/2007
Interleukin Genetics Reports First Quarter 2007 Financial Results
05/03/2007
Interleukin Genetics to Host First Quarter 2007 Financial Results Conference Call On May 9
04/09/2007
Interleukin To Hold Investor Meeting On June 12 Following Annual Meeting
04/02/2007
Interleukin Genetics Reports 2006 Year-End and Fourth Quarter Financial Results
03/31/2007
Interleukin Genetics to Host Fourth Quarter and Fiscal 2006 Financial Results Conference Call Apr. 2
03/30/2007
Interleukin Genetics Expands Research Collaboration with Alticor
03/27/2007
ACC Presentation Indicates IL-1 Gene Variants Determine Increased Risk for Coronary Artery Disease
03/15/2007
Interleukin Genetics Postpones Fourth Quarter And Fiscal 2006 Financial Results Conference Call
11/08/2006
Interleukin Genetics Reports Third Quarter Financial Results
11/03/2006
Interleukin Genetics To Host Third Quarter 2006 Financial Results Conference Call On November 8
11/02/2006
Interleukin Genetics Sponsors Expert Meeting On The Role Of Inflammation In Aging
09/07/2006
Interleukin Genetics Initiates Study Of IL-1 Gene Variation And Osteoporosis In Korean Women
08/17/2006
Interleukin Genetics Acquires Alan James Group and Secures $30 Million in New Financing
08/09/2006
Interleukin Genetics Reports Second Quarter Financial Results
07/05/2006
Interleukin Genetics CEO Presents at Opening Session of EuroPerio 5 Meeting
06/28/2006
Interleukin Genetics Expands DNA Analysis Lab Operations to Meet Demand for Risk Assessment Tests
06/21/2006
Interleukin Genetics Licenses DNA-Based Weight Management Technology From GeneOb
06/19/2006
Interleukin Genetics Initiates Study Of IL-1 Variations and Incidence Of Early Stroke In Italian Pop
06/14/2006
ILI Reports On Annual Stockholder Meeting And Announces New Director
05/16/2006
Interleukin Genetics CEO to present at Korean Conference on Aging
05/12/2006
Dr. Philip Reilly elected to Board of Trustees at Cornell University
05/09/2006
Interleukin Genetics Reports First Quarter Financial Results
03/31/2006
Interleukin Genetics Announces Changes in Executive Management
03/14/2006
Interleukin Genetics Reports Fourth Quarter And Year-End Financial Results
02/28/2006
Interleukin Genetics Enters Into New Agreements and Amends Agreements with Alticor
01/11/2006
Research on genetic variation and inflammation..
12/28/2005
Interleukin Genetics on the American Stock Exchange...
11/04/2005
Interleukin Genetics Reports Third Quarter Financial Results
08/03/2005
Interleukin Genetics Reports Second Quarter Financial Results
07/26/2005
Interleukin Genetics Announces Changes in Senior Management
07/11/2005
Interleukin Genetics Names Ramon W. Mohanlal, M.D. as Chief Medical Officer
07/07/2005
Interleukin Genetics Regains Compliance with OTCBB Requirements
06/30/2005
Interleukin Genetics Files Form 10-K/A For Fiscal Year 2004
06/16/2005
Interleukin Genetics NASD Hearing Rescheduled
06/13/2005
Interleukin Genetics Appeals NASD Determination
05/05/2005
Interleukin Genetics Reports First Quarter Financial Results
04/26/2005
Interleukin Genetics Restates Its 2003 and 2004 Financial Statements
04/25/2005
Interleukin Achieves Milestone and Receives $2 Million Pre-payment
04/07/2005
Interleukin Genetics Updates Status of Filing Annual Report on Form 10-K ...
04/01/2005
Interleukin Genetics Announces Delay in filing Annual Report on Form 10-K ...
03/16/2005
Interleukin Genetics Reports Fourth Quarter and Year-End Results
03/03/2005
Interleukin Genetics extends Research Collaboration, Modifies Stock Purchase and Product ...